Table 2
n | Cyr61 | P | CTGF | P | Nov | P | |
PV thrombosis | |||||||
Present | 16 | 2.59 ± 0.41 | 0.024 | 2.41 ± 0.39 | 0.031 | 1.45 ± 0.56 | 0.147 |
Absent | 15 | 2.08 ± 0.65 | 2.10 ± 0.58 | 1.56 ± 0.45 | |||
AFP level | |||||||
≤ 20 ng/mL | 19 | 2.26 ± 0.48 | 0.068 | 2.21 ± 0.20 | 0.063 | 1.38 ± 0.43 | 0.241 |
> 20 ng/mL | 12 | 2.36 ± 0.71 | 2.23 ± 0.84 | 1.66 ± 0.71 | |||
Tumor size (cm) | |||||||
≤ 5 cm | 20 | 2.35 ± 0.86 | 0.124 | 2.26 ± 0.79 | 0.071 | 1.59 ± 0.58 | 0.251 |
> 5 cm | 11 | 2.32 ± 0.41 | 2.09 ± 0.53 | 1.55 ± 0.31 | |||
Capsule formation | |||||||
Positive | 18 | 2.35 ± 0.34 | 0.136 | 2.31 ± 0.34 | 0.132 | 1.87 ± 0.65 | 0.135 |
Negative | 13 | 2.33 ± 0.67 | 2.15 ± 0.87 | 1.36 ± 0.81 | |||
Histological grade | |||||||
I-II | 13 | 2.21 ± 0.39 | 0.052 | 1.89 ± 0.54 | 0.022 | 1.35 ± 0.47 | 0.132 |
III-IV | 18 | 2.51 ± 0.41 | 2.51 ± 0.61 | 1.58 ± 0.68 |
PV: portal vein.